XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Assets:    
Cash and cash equivalents $ 12,116 $ 9,408
Investments 2,877 3,117
Accounts receivable, net 27,233 24,431
Inventories 17,375 17,760
Other current assets 2,541 5,292
Total current assets 62,142 60,008
Long-term investments 21,124 23,025
Property and equipment, net 12,764 12,896
Operating lease right-of-use assets 18,562 19,122
Goodwill 78,560 79,121
Intangible assets, net 28,135 29,026
Separate accounts assets 4,140 5,087
Other assets 4,852 4,714
Total assets 230,279 232,999
Liabilities:    
Accounts payable 13,238 12,544
Pharmacy claims and discounts payable 18,393 17,330
Health care costs payable 10,400 8,808
Policyholders’ funds 1,628 4,301
Accrued expenses 17,728 17,670
Other insurance liabilities 1,197 1,303
Current portion of operating lease liabilities 1,854 1,646
Current portion of long-term debt 4,019 4,205
Total current liabilities 68,457 67,807
Long-term operating lease liabilities 17,502 18,177
Long-term debt 50,797 51,971
Deferred income taxes 5,450 6,270
Separate accounts liabilities 4,140 5,087
Other long-term insurance liabilities 6,287 6,402
Other long-term liabilities 2,140 1,904
Total liabilities 154,773 157,618
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,755 shares issued and 1,312 shares outstanding at June 30, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus 47,874 47,377
Treasury stock, at cost: 443 shares at June 30, 2022 and 422 shares at December 31, 2021 (30,412) (28,173)
Retained earnings 58,710 54,906
Accumulated other comprehensive income (loss) (988) 965
Total CVS Health shareholders’ equity 75,184 75,075
Noncontrolling interests 322 306
Total shareholders’ equity 75,506 75,381
Total liabilities and shareholders’ equity $ 230,279 $ 232,999